Drug
Lubt010
Lubt010: highest development phase Phase 3, developed by Lupin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Lupin
Trials
| Drug | Phase | Indication |
|---|---|---|
| LUBT010 (proposed ranibizumab biosimilar) NCT04690556 | Phase 3 | Neovascular Age-related Macular Degeneration |
Latest
No recent events.
Follow Lubt010 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.